Christopher Thomas Giordano insider trades

Open-market stock purchases and sales by Christopher Thomas Giordano, CEO at Tenax Therapeutics, Inc, from SEC Form 4 filings since Jun 9, 2022.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -45%.

Recent trades

DateStockTradeValue
Sep 15, 2026TENX Tenax Therapeutics, IncBought$8.8K
Sep 11, 2026TENX Tenax Therapeutics, IncBought$11.3K
Jan 9, 2026TENX Tenax Therapeutics, IncBought (not open market)—
Nov 20, 2025TENX Tenax Therapeutics, IncBought$4.1K
Nov 19, 2025TENX Tenax Therapeutics, IncBought$3.4K
Nov 18, 2025TENX Tenax Therapeutics, IncBought$12.5K

Companies traded

  • TENX Tenax Therapeutics, Inc: 5 buys, last Sep 15, 2026

Get free alerts when Christopher Thomas Giordano files a new trade →